Search company, investor...

Founded Year



Convertible Note | Alive

Total Raised


Last Raised

$1.6M | 4 mos ago

About GreenSpense

GreenSpense focuses on developing innovative, propellant-free continuous dispensing technology in the personal care, home care, healthcare, food, and technical sectors. The company offers a continuous dispensing system that eliminates the need for pressurized canisters, allowing for the use of low-cost, recyclable materials such as plastic or cardboard in product packaging. The company primarily serves the personal care, home care, healthcare, food, and technical industries. It was founded in 2011 and is based in Haifa, Israel.

Headquarters Location

55 Margalit





Expert Collections containing GreenSpense

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

GreenSpense is included in 1 Expert Collection, including Packaging & Labeling Tech.


Packaging & Labeling Tech

617 items

Companies providing traditional and tech-enabled packaging and labeling solutions for brands.

GreenSpense Patents

GreenSpense has filed 10 patents.

The 3 most popular patent topics include:

  • brands of toothpaste
  • cleaning products
  • cosmetics
patents chart

Application Date

Grant Date


Related Topics




Fluid dynamics, Industrial gases, Gas technologies, Surface science, Conoidasida


Application Date


Grant Date



Related Topics

Fluid dynamics, Industrial gases, Gas technologies, Surface science, Conoidasida



Latest GreenSpense News

700 for Science Announces Picks for 2014 Portfolio700

Feb 25, 2014

FASEB announces 2014 Science Research Conference: Molecular Biophysics of Membranes 700 for Science, a global nonprofit organization comprised of scientists, industry leaders and investors in early-stage biotech and clean technologies with potential far-reaching social impact, today announced the companies selected for its 2014 Portfolio700 – Bioneedle Technologies Group, GreenSpense, p53 -Therapeutics and Reflexion Pharmaceuticals. “Portfolio700 identifies some of the most promising innovations emerging worldwide and showcases them in an investor-friendly format to help young companies reach a wider audience of commercialization experts and potential industry partners,” said Catarina Wylie, co-founder of 700 for Science . “Our goal is to open doors and make useful introductions for entrepreneurs and the startups they’ve launched.” This year’s picks: Bioneedle Technologies Group – Vaccinations are widely considered the best, cheapest and most effective way to protect against a growing list of infectious diseases . But ambitious vaccine programs are currently hampered by an outmoded delivery system. The Bioneedle vaccine-delivery platform offers an innovative solution for developing countries and a rapid-response mechanism to address worldwide public health emergencies. GreenSpense – Convenient as they are, aerosol cans are hazardous to the environment because they rely on volatile organic compounds to propel a product from the canister. VOCs contribute to air pollution and are a factor in climate change. Aerosols are also expensive to produce, often dangerous to ship and store, and put a crimp in creative packaging options. The GreenSpense eco-sleeve is a smarter, cheaper, eco-friendly solution. p53-Therapeutics – The p53 gene is known as the guardian of the genome. It’s one of the body’s critical damage-control genes, repairing cells when possible, telling them to self-destruct when things are beyond repair. When something goes wrong here, cancer cells can grow at will. p53-Therapeutics is developing customized chemotherapies to restore the enforcer function of the p53 gene. Reflexion Pharmaceuticals – Every protein molecule in the body is left-handed, which has profoundly shaped the way drugs are developed. The innovation? Protein therapeutics created from mirror images of naturally occurring proteins. Known as D-proteins, these mirror-image proteins can zero in on targets because they are 20 times smaller than the body's natural proteins. They also virtually eliminate toxic side effects and can be administered in whatever form needed to best treat a specific disease – small volume/high concentration injections, sustained release, inhalants. “These highly creative companies have been selected by the 700 for Science member network, a bottom-up support system for innovative projects and technologies,” said Wylie. “We want to draw attention to their efforts in hopes of helping them reach their next critical milestones.” About 700 for Science 700 for Science is an elite group of professionals involved in the research, development and commercialization of biotech and clean technologies. Members are invited to join the global organization based on professional expertise and a demonstrated willingness to further the nonprofit’s mission of advancing bold projects with inherent social value. Collectively, the group forms a bottom-up support system by providing market insights, making useful introductions and supplying practical how to information. For more information visit 700 for Science . You can also follow 700 for Science news on Twitter and LinkedIn . 700 for Science

GreenSpense Frequently Asked Questions (FAQ)

  • When was GreenSpense founded?

    GreenSpense was founded in 2011.

  • Where is GreenSpense's headquarters?

    GreenSpense's headquarters is located at 55 Margalit, Haifa.

  • What is GreenSpense's latest funding round?

    GreenSpense's latest funding round is Convertible Note.

  • How much did GreenSpense raise?

    GreenSpense raised a total of $1.6M.

  • Who are the investors of GreenSpense?

    Investors of GreenSpense include Horizon 2020 and The Trendlines Group.

  • Who are GreenSpense's competitors?

    Competitors of GreenSpense include Lumson, Airopack, TIPA, AeroFlexx, Ophardt Hygiene Technologies and 7 more.


Compare GreenSpense to Competitors

ProAmpac Logo

ProAmpac focuses on flexible packaging. It offers creative packaging solutions, including rollstock, pouches, and bags, designed to preserve and protect a variety of products. ProAmpac primarily serves sectors such as e-commerce, food and beverage, healthcare, and home and personal care. ProAmpac was formerly known as Prolampac. The company was founded in 2015 and is based in Cincinnati, Ohio.


Lumson produces packaging products for the beauty industry. Its product categories include airless, dispensing systems, glass jars, bottles, plastic bottles, compact cases, and more. The company was founded in 1975 and is based in Cremona, Italy.


ETICOD is a label printing company specializing in the production of self-adhesive labels for various industries. The company offers high-quality label printing services using flexographic and digital printing technologies, and provides a range of label enhancements such as hotstamping, embossing, and UV varnishing. ETICOD primarily serves sectors such as the alcohol, beverage, cosmetic, pharmaceutical, technical, logistics, automotive, food, advertising, chemical, and construction industries. It was founded in 1994 and is based in Katowice, Poland.

Beucke Group

Beucke Group specializes in the production of high-quality, enhanced flexible packaging within the printing industry. The company offers a range of packaging solutions including mono and composite films, substrates from renewable resources, and various finishing processes such as lamination, roll cutting, hot melt, punching, coding, and cold seal applications. Beucke Group primarily serves the food, tobacco, and non-food sectors with its packaging products. It was founded in 1757 and is based in Osnabruck, Germany.


MENSHEN is a manufacturer of closures, plastic solutions, and packaging systems. It offers a wide range of closures for bags, bottles, sponge applicators, and tubes. It was founded in 1970 and is based in Finnentrop, Germany.


Solutum develops plastic-like bags. Its bags are capable of fully dissolving in water. It enables users to use products that are cost-efficient and eco-friendly, and protect the environment. It was founded in 2017 and is based in Tel Aviv, Israel.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.